Market Research Logo

Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2016

Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2016’, provides an overview of the Takeda Pharmaceutical Company Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Takeda Pharmaceutical Company Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Takeda Pharmaceutical Company Limited
  • The report provides overview of Takeda Pharmaceutical Company Limited including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Takeda Pharmaceutical Company Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Takeda Pharmaceutical Company Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Takeda Pharmaceutical Company Limited’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Takeda Pharmaceutical Company Limited
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Takeda Pharmaceutical Company Limited’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Takeda Pharmaceutical Company Limited Snapshot
Takeda Pharmaceutical Company Limited Overview
Key Information
Key Facts
Takeda Pharmaceutical Company Limited - Research and Development Overview
Key Therapeutic Areas
Takeda Pharmaceutical Company Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
Takeda Pharmaceutical Company Limited - Pipeline Products Glance
Takeda Pharmaceutical Company Limited - Late Stage Pipeline Products
Takeda Pharmaceutical Company Limited - Clinical Stage Pipeline Products
Takeda Pharmaceutical Company Limited - Early Stage Pipeline Products
Takeda Pharmaceutical Company Limited - Drug Profiles
(alogliptin benzoate + metformin hydrochloride)
(alogliptin benzoate + pioglitazone hydrochloride)
brentuximab vedotin
ceftaroline fosamil
ixazomib citrate
ramelteon
vedolizumab
roflumilast
(amlodipine besylate + azilsartan medoxomil + hydrochlorothiazide)
azilsartan medoxomil
febuxostat XR
immune globulin (human)
pioglitazone hydrochloride
rasagiline mesylate
relugolix
TAK-003
vortioxetine hydrobromide
AM-4
DSM-265
namilumab
TAK-063
TAK-214
TAK-272
TAK-850
J-591
TAK-020
TAK-021
TAK-058
TAK-071
TAK-079
TAK-653
TAK-792
TAK-828
TAK-831
TAK-915
TAK-935
trelagliptin succinate
(plague + small pox) vaccine
BTZO-2
chikungunya vaccine
ELQ-300
influenza [strain A/H5N1] vaccine
influenza [strains A/H1N1 + A/H3N2 + A/H5N1] (virus like particle) vaccine
mapatumumab
Monoclonal Antibody Conjugate to Target c-Ret for Breast Cancer
Monoclonal Antibody Conjugate to Target Guanylyl Cyclase C for Oncology
Monoclonal Antibody Conjugates for Oncology
respiratory syncytial virus (virus like particle) vaccine
Rotavirus (virus like particle) vaccine
Small Molecule 1 to Inhibit Dopamine Transporter, Noradrenaline Transporter and Serotonin Transporter for Depression
Small Molecule 2 to Inhibit Gamma Secretase for Alzheimer's Disease
Small Molecule to Activate Glucokinase for Type 2 Diabetes
Small Molecule to Agonize Cannabinoid Receptor for Inflammatory Pain
Small Molecule to Agonize GPR52 for Psychiatry Disorders
Small Molecule to Antagonize Androgen Receptor for Prostate Cancer
Small Molecule to Antagonize CRF1 for CNS Disorders
Small Molecule to Antagonize Farnesoid X Receptor for Dyslipidemia
Small Molecule to Antagonize MCHR1 for Obesity
Small Molecule to Antagonize Mineralocorticoid Receptor for Hypertension
Small Molecule to Antagonize PDGFR and VEGFR-2 for Oncology
Small Molecule to Inhibit Dopamine Transporter, Noradrenaline Transporter and Serotonin Transporter for Depression
Small Molecule to Inhibit FAAH for Pain
Small Molecule to Inhibit Gamma Secretase for Alzheimer's Disease
Small Molecule to Inhibit HER2/EGFR for Oncology
Small Molecule to Inhibit NET for Stress Urinary Incontinence
Small Molecule to Inhibit PKC-Theta
Small Molecules for Parkinson's Disease
Small Molecules for Visceral Leishmaniasis
Small Molecules to Agonize GPR119 for Type II Diabetes
Small Molecules to Inhibit Acetyl-CoA Carboxylase for Obesity
Small Molecules to Inhibit B-Raf for Oncology
Small Molecules to Inhibit CENP-E for Colon Cancer
Small Molecules to Inhibit DPP-IV for Type 2 Diabetes
Small Molecules to Inhibit Hedgehog Signaling for Medulloblastoma
Small Molecules to Inhibit MAP2 for Obesity
Small Molecules to Inhibit MGAT2 for Metabolic Disorders
Small Molecules to Inhibit MMP-13 for Osteoarthritis
Small Molecules to Inhibit PARP-1 for Colon Cancer
Small Molecules to Inhibit TYK2
Stem Cell Therapy for Muscular Dystrophy
T-1840383
T-3256336
TAK-041
TAK-480
TAK-632
Y-443
Small Molecule for Undisclosed Indication
Small Molecule to Inhibit Arginine Methyltrasferase for Oncology
Small Molecule to Inhibit HDAC6
Small molecules for Leishmaniasis and Trypanosomiasis
Small Molecules for Malaria
Small Molecules for Tuberculosis
Small Molecules to Inhibit Apoptosis Signal-Regulating Kinase 1
Small Molecules to Inhibit FAK for Oncology
Small Molecules to Inhibit HER2 and EGFR for Oncology
Small Molecules to Inhibit IAP for Oncology
Small Molecules to Inhibit Mcl-1 and Bcl-xL for Oncology
Y-142
Takeda Pharmaceutical Company Limited - Pipeline Analysis
Takeda Pharmaceutical Company Limited - Pipeline Products by Target
Takeda Pharmaceutical Company Limited - Pipeline Products by Route of Administration
Takeda Pharmaceutical Company Limited - Pipeline Products by Molecule Type
Takeda Pharmaceutical Company Limited - Pipeline Products by Mechanism of Action
Takeda Pharmaceutical Company Limited - Recent Pipeline Updates
Takeda Pharmaceutical Company Limited - Dormant Projects
Takeda Pharmaceutical Company Limited - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Takeda Pharmaceutical Company Limited - Company Statement
Takeda Pharmaceutical Company Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Takeda Pharmaceutical Company Limited, Key Information
Takeda Pharmaceutical Company Limited, Key Facts
Takeda Pharmaceutical Company Limited - Pipeline by Indication, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Stage of Development, 2016
Takeda Pharmaceutical Company Limited - Monotherapy Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Combination Treatment Modalities in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Partnered Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Partnered Products/ Combination Treatment Modalities, 2016
Takeda Pharmaceutical Company Limited - Out-Licensed Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Out-Licensed Products/ Combination Treatment Modalities, 2016
Takeda Pharmaceutical Company Limited - Pre-Registration, 2016
Takeda Pharmaceutical Company Limited - Filing rejected/Withdrawn, 2016
Takeda Pharmaceutical Company Limited - Phase III, 2016
Takeda Pharmaceutical Company Limited - Phase II, 2016
Takeda Pharmaceutical Company Limited - Phase I, 2016
Takeda Pharmaceutical Company Limited - Phase 0, 2016
Takeda Pharmaceutical Company Limited - IND/CTA Filed, 2016
Takeda Pharmaceutical Company Limited - Preclinical, 2016
Takeda Pharmaceutical Company Limited - Discovery, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Target, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Route of Administration, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Molecule Type, 2016
Takeda Pharmaceutical Company Limited - Pipeline Products by Mechanism of Action, 2016
Takeda Pharmaceutical Company Limited - Recent Pipeline Updates, 2016
Takeda Pharmaceutical Company Limited - Dormant Developmental Projects,2016
Takeda Pharmaceutical Company Limited - Discontinued Pipeline Products, 2016
Takeda Pharmaceutical Company Limited, Other Locations
Takeda Pharmaceutical Company Limited, Subsidiaries
List of Figures
Takeda Pharmaceutical Company Limited - Pipeline by Top 10 Indication, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Stage of Development, 2016
Takeda Pharmaceutical Company Limited - Monotherapy Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Combination Treatment Modalities in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Partnered Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Out-Licensed Products in Pipeline, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Top 10 Target, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Route of Administration, 2016
Takeda Pharmaceutical Company Limited - Pipeline by Molecule Type, 2016
Takeda Pharmaceutical Company Limited - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report